Overview

DILIPO (DILutIonal HyPOnatremia)

Status:
Completed

Trial end date:
2007-07-01

Target enrollment:

Participant gender:

Summary

Primary: - To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis Secondary: - To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients - To assess the safety and tolerability of SR121463B

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Satavaptan